Revenue segments as reported by the company.

Premium and service revenues

Premium tax

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Depreciation

Amortization of acquired intangible assets

Premium tax expense

Health insurer fee expense

Impairment

Legal settlement

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Centene

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Centene exceeds earnings guidance, eyes growth in Marketplace products

Centene's Q4 2022 earnings call highlighted robust financial performance, successful execution of value-creation plans, and a focus on operational efficiency. While challenges in Medicare Advantage margins are anticipated, opportunities in the Marketplace business and cost-cutting initiatives offer avenues for growth. Strategic initiatives to address demographic shifts and enhance care relationships position Centene for future success.

Centene reports strong Q1 earnings, focuses on growth opportunities

Centene's Q1 performance reflects strength in financial results and a strategic outlook for future growth.
Despite challenges in Medicare profitability and Medicaid redeterminations, Centene remains focused on maximizing membership and maintaining high margins.
Opportunities in enhancing relationships, investing in infrastructure, and updating margin assumptions position Centene for long-term success.

Centene reports strong Q2 earnings, raises 2023 outlook amidst challenges

Centene's Q2 earnings call showcased robust financial performance, operational efficiencies, and strategic wins in Medicaid and Marketplace segments. While facing challenges in cost trends and Star ratings strategy, the company is well-positioned for growth through revenue expansion and value-creation initiatives. Opportunities for engagement with key stakeholders and successful outreach efforts present avenues for continued success.

Centene exceeds Q3 earnings expectations, eyes growth opportunities in 2024

Centene's Q3 2023 earnings call highlighted strong financial performance, progress in Medicaid redeterminations, and operational advancements. The company anticipates continued growth in adjusted EPS for 2023 and 2024, with a focus on margin expansion and operational efficiencies. Challenges include managing membership declines and addressing questions on business plans and cost implications.

Centene exceeds 2023 expectations, poised for growth in 2024

Centene's 2023 performance was strong, exceeding expectations and positioning the company for continued growth. Key initiatives in Medicaid, Medicare Advantage, and Marketplace are driving revenue growth and operational efficiency. Challenges in managing utilization trends and achieving target margins require ongoing attention.

Centene surpasses Q1 earnings expectations, eyes growth in Medicaid and Marketplace

Centene's Q1 performance exceeded expectations, showcasing strength in Medicaid and Marketplace segments.
While facing challenges in contract protests and operational clarity, the company's strategic focus on Medicare Advantage and growth opportunities remain key strengths.
With a robust financial outlook and ongoing initiatives for optimization, Centene is well-positioned for continued success in the healthcare market.
Investors can be optimistic about Centene's growth trajectory, supported by strong operational performance and strategic initiatives.

Centene reports robust Q2 earnings, eyes Medicaid rebound and Medicare growth

Centene's Q2 2024 earnings call highlighted strong performance, Medicaid challenges, and growth opportunities in Medicaid and Medicare markets. Leadership transitions and focus on program innovation are key areas of development for the company.

Centene surpasses Q3 earnings expectations, eyes growth amid challenges

Centene's Q3 performance exceeded expectations, driven by improvements in Medicaid and strong Medicare and Marketplace segments.
Despite challenges in Medicaid and competitive pressures, Centene remains confident in its future growth and operational enhancements.
The company's strategic focus on AI, margin expansion, and quality improvement positions it well for continued success and profitability.
Analyst inquiries and company responses highlighted key areas of focus and potential areas for improvement and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

ST. LOUIS , May 24, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today it has named Shannon T. Susko as its Senior Vice President and Chief Communications Officer.

CENTENE CORPORATION ANNOUNCES NEW CHIEF COMMUNICATIONS OFFICER

Centene's (CNC) health benefit ratio is estimated at 87.1-87.7% for 2023, signaling better operating efficiency.

Here's Why Hold Strategy is Apt for Centene (CNC) Stock Now

Amgen

Bristol-Myers

Cigna

Gilead Sciences

Labcorp Holdings Inc

Organon & Co

Pfizer

Viatris

The stocks our screen found are cheap, relative to highfliers like Eli Lilly, and many are cheap for a reason.

9 Cheap Healthcare Stocks to Consider

ST. LOUIS , May 15, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, today announced that Alice Hm Chen, M.D., MPH, Centene's Chief Health Officer (CHO), has been appointed as an Executive Forum co-chair of the Health Care Payment Learning & Action Network (LAN), an organization of public and private healthcare leaders committed to the use of thought leadership, strategic direction and efforts to accelerate adoption of alternative payment models (APM).

Alice Hm Chen M.D., MPH, Named Executive Forum Co-Chair of the Health Care Payment Learning & Action Network

ST. LOUIS , May 12, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it will present at the Bernstein 39th Annual Strategic Decisions Conference, to be held Wednesday, May 31-Friday, June 2, 2023, in New York City. Centene will present on Thursday, June 1 st at 9:00 a.m.

CENTENE TO PRESENT AT BERNSTEIN 39TH ANNUAL STRATEGIC DECISIONS CONFERENCE

SelectQuote

OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of an emerging Healthcare Services platform, today announced that Wellcare, the Medicare brand of Centene Corporation (NYSE: CNC), named SelectQuote a Preferred Medicare Sales and Distribution Partner. SelectQuote CEO Tim Danker commented, “We are excited to continue the strong partnership we have built with Wellcare over the past few years. Our differentiated app.

SelectQuote Named to Wellcare Preferred Medicare Sales and Distribution Partnership Program

Program aims to strengthen sales partnerships, enhance customer experience and improve quality TAMPA, Fla. , May 10, 2023 /PRNewswire/ -- Today, Wellcare, the Medicare brand of Centene Corporation (NYSE: CNC), announced the launch of a preferred Medicare sales and distribution partnership program to strengthen its Medicare sales partnerships, enhance the customer experience and improve quality.

Wellcare Launches Preferred Medicare Sales and Distribution Partnership Program

ST. LOUIS , May 4, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today it was named a DiversityInc Top 50 Company for Diversity for the fourth consecutive year. "It is an honor to once again be recognized by DiversityInc," said Sarah M.

CENTENE CORPORATION NAMED A TOP 50 COMPANY FOR DIVERSITY BY DIVERSITYINC

Centene Corp will sell its artificial intelligence-powered healthcare analytics platform Apixio to investment firm New Mountain Capital as part of an ongoing portfolio review, the U.S. health insurer said on Wednesday.

Centene to divest AI platform Apixio

ST. LOUIS , May 3, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that it has signed a definitive agreement to sell Apixio, a leading artificial intelligence platform that enables value-based care, to New Mountain Capital, a growth-oriented investment firm with more than $37 billion in assets under management. Centene acquired Apixio in December 2020.

CENTENE CORPORATION SIGNS DEFINITIVE AGREEMENT TO DIVEST APIXIO TO NEW MOUNTAIN CAPITAL

The need for health insurance is only growing, and Centene is one of the biggest providers. Centene's growing membership base helped fuel solid results in the first quarter.

Attention Value Investors: This Healthcare Stock Could Be a No-Brainer Buy

Centene's (CNC) first-quarter 2023 results grapple with higher operating expenses, partly offset by an expanding customer base. Management presently expects adjusted EPS to be at least $6.40 in 2023.

Centene (CNC) Q1 Earnings Miss Estimates, '23 EPS View Raised

Centene Corporation (CNC) Q1 2023 Earnings Call Transcript.

Centene Corporation (CNC) Q1 2023 Earnings Call Transcript

The headline numbers for Centene (CNC) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Centene (CNC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Centene (CNC) came out with quarterly earnings of $2.11 per share, missing the Zacks Consensus Estimate of $2.23 per share. This compares to earnings of $1.83 per share a year ago.

Centene (CNC) Misses Q1 Earnings Estimates

-- Diluted E PS of $2.04; Adjusted Diluted EPS of $2.11 -- --  Increases 2023 Full Year Guidance and Updates 2024 Target -- Increased 2023 full year Adjusted EPS guidance to at least $6.40 driven by strong performance in its market leading Medicaid and Marketplace businesses. Premium and service revenues of $35.0 billion in the first quarter of 2023.

CENTENE CORPORATION REPORTS FIRST QUARTER 2023 RESULTS

Centene's (CNC) first-quarter results are likely to reflect growth in premiums and lower costs.

Will Lower Managed Care Profits Hurt Centene's (CNC) Q1 Earnings?

ST. LOUIS , April 20, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it has named Anika Gardenhire RN, BSN, MMCI as its Chief Customer Experience Officer (CXO). In her new role, Ms.

CENTENE CORPORATION NAMES ANIKA GARDENHIRE CHIEF CUSTOMER EXPERIENCE OFFICER

Citigroup

CVS Health

Investing in the stock market under the current economic uncertainties can be confusing and risky. However, looking for companies with a proven growth and stability track record is a prudent place to start searching for investment opportunities regardless of the macroeconomic situation.

3 Stocks With Proven Growth Records

Continued Medicaid expansion bodes well for Centene. Viatris' drug pipeline should deliver modest growth in the years ahead.

Wall Street Thinks These 2 Value Stocks Could Soar

Fred Eppinger to assume role of Chairman of the Centene Board Wayne DeVeydt to assume role of Chairman of the Audit and Compliance Committee Orlando Ayala, Richard Gephardt and William Trubeck to retire from the Board effective May 10, 2023 ST. LOUIS , April 3, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today that Fred Eppinger will assume the role of Chairman of the Centene Board of Directors, and Wayne DeVeydt will assume the role of Chairman of the Audit and Compliance Committee.

CENTENE ANNOUNCES CHANGES TO BOARD OF DIRECTORS

ST. LOUIS , March 31, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) today announced that it will release its 2023 first quarter financial results at approximately 6 a.m. (Eastern Time) on Tuesday, April 25, 2023, and will host a conference call afterwards at approximately 8:30 a.m.

CENTENE CORPORATION SCHEDULES 2023 FIRST QUARTER FINANCIAL RESULTS CONFERENCE CALL

ST. LOUIS , March 31, 2023 /PRNewswire/ -- Centene Corporation (NYSE: CNC) announced today it has been named one of America's Most Innovative Companies by Fortune magazine. Centene is one of 300 companies included on the inaugural list.

CENTENE RECOGNIZED BY FORTUNE AS ONE OF "AMERICA'S MOST INNOVATIVE COMPANIES"

Centene (CNC) expands the use of Evolent's oncology specialty care to improve cost management.

Centene (CNC) Expands Evolent Partnership to Boost Quality

Health Net Assisting Members in Alameda, Marin, Modoc and Shasta Counties During State of Emergency SACRAMENTO, Calif. , March 29, 2023 /PRNewswire/ -- In response to Gov.

News for Centene Stock (CNC)